BAN2401-G000-201 BAN2401 in Early Alzheimer's Disease

• Research type

  Research Study

• Full title

  A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease

• IRAS ID

  118666

• Contact name

  Roger Bullock

• Contact email

  roger.bullock@awp.nhs.uk

• Sponsor organisation

  Eisai Limited

• Eudract number

  2012-002843-11

• Clinicaltrials.gov Identifier

  NCT01767311

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  13/SC/0286

• Date of REC Opinion

  20 Aug 2013

• REC opinion

  Further Information Favourable Opinion